7 min listen
Unavailable
ratings:
Length:
6 minutes
Released:
Nov 11, 2019
Format:
Podcast episode
Description
If the researchers, executives and investors behind Coda Biotherapeutics have their way, one day soon there really could be a cure for pain. Co-founded by researchers Joseph Glorioso, from the University of Pittsburgh’s microbiology and molecular genetics department; and Dr. Nicholas Boulis, the founder of Emory’s Gene and Cell Therapy for Neurorestoration Laboratory; Coda uses gene therapies to treat neurological diseases starting with severe pain and epilepsy.
Released:
Nov 11, 2019
Format:
Podcast episode
Titles in the series (100)
Bolt adds $75M to its Series C, as the battle to rule online checkout continues by TechCrunch Startup News